Identification of monosomy 3 in choroidal melanoma by chromosome in situ hybridisation
- PMID: 15548805
- PMCID: PMC1772433
- DOI: 10.1136/bjo.2004.044768
Identification of monosomy 3 in choroidal melanoma by chromosome in situ hybridisation
Abstract
Background/aims: In uveal melanoma monosomy 3 is emerging as a significant indicator of a poor prognosis. To date most cytogenetic studies of uveal melanoma have utilised fresh tissue or DNA extracted from tissue sections. In this study chromosome in situ hybridisation (CISH) was used to study monosomy 3 in tissue sections. The copy number of chromosome 3 was determined and related to patient survival.
Methods: Archival glutaraldehyde or formalin fixed, paraffin embedded material was obtained from 30 metastasising and 26 non-metastasising choroidal melanomas. Hybridisations were performed using centromere specific probes to chromosomes 3 and 18. Chromosome 18 was included as a control as previous abnormalities in uveal melanoma have not been described. Chromosomal imbalance was defined on the basis of changes in both chromosome index and signal distribution.
Results: CISH was successfully performed on both glutaraldehyde and formalin fixed tissue. Four cases were unsuccessful because of extensive tumour necrosis. All cases were balanced for chromosome 18. Monosomy 3 was detected in 15 of the 26 cases of metastasising melanoma; the 26 non-metastasising tumours were all balanced for chromosome 3. Monosomy 3 was significantly associated with metastases related death.
Conclusion: CISH can successfully identify monosomy 3 in archival glutaraldehyde or formalin fixed, paraffin embedded tissue sections. Similar to previous studies monosomy 3 is a significant predictor of metastases related death.
Figures



Similar articles
-
An alternative hypothesis for observed mortality rates due to metastasis after treatment of choroidal melanomas of different sizes.Trans Am Ophthalmol Soc. 2007;105:54-59; discussion 59-60. Trans Am Ophthalmol Soc. 2007. PMID: 18427594 Free PMC article. Review.
-
Chromosome 3 intratumor heterogeneity in uveal melanoma.Invest Ophthalmol Vis Sci. 2009 Feb;50(2):500-4. doi: 10.1167/iovs.08-2279. Epub 2008 Sep 29. Invest Ophthalmol Vis Sci. 2009. PMID: 18824727
-
Correlation of heterogeneity for chromosome 3 copy number with cell type in choroidal melanoma of mixed-cell type.Invest Ophthalmol Vis Sci. 2006 Dec;47(12):5177-80. doi: 10.1167/iovs.06-0332. Invest Ophthalmol Vis Sci. 2006. PMID: 17122100
-
The heterogeneous distribution of monosomy 3 in uveal melanomas: implications for prognostication based on fine-needle aspiration biopsies.Arch Pathol Lab Med. 2007 Jan;131(1):91-6. doi: 10.5858/2007-131-91-THDOMI. Arch Pathol Lab Med. 2007. PMID: 17227129
-
Monosomy 3 by FISH in uveal melanoma: variability in techniques and results.Surv Ophthalmol. 2012 Sep;57(5):463-73. doi: 10.1016/j.survophthal.2011.12.004. Epub 2012 Jun 2. Surv Ophthalmol. 2012. PMID: 22658782 Review.
Cited by
-
Emerging roles of microRNAs and their implications in uveal melanoma.Cell Mol Life Sci. 2021 Jan;78(2):545-559. doi: 10.1007/s00018-020-03612-w. Epub 2020 Aug 11. Cell Mol Life Sci. 2021. PMID: 32783068 Free PMC article. Review.
-
An alternative hypothesis for observed mortality rates due to metastasis after treatment of choroidal melanomas of different sizes.Trans Am Ophthalmol Soc. 2007;105:54-59; discussion 59-60. Trans Am Ophthalmol Soc. 2007. PMID: 18427594 Free PMC article. Review.
-
Radiation-Induced DNA Damage in Uveal Melanoma Is Influenced by Dose Delivery and Chromosome 3 Status.Invest Ophthalmol Vis Sci. 2024 Jun 3;65(6):7. doi: 10.1167/iovs.65.6.7. Invest Ophthalmol Vis Sci. 2024. PMID: 38833258 Free PMC article.
-
Cytogenetic and immunohistochemical study of 42 pigmented microcystic chromophobe renal cell carcinoma (PMChRCC).Virchows Arch. 2018 Aug;473(2):209-217. doi: 10.1007/s00428-018-2389-y. Epub 2018 Jun 21. Virchows Arch. 2018. PMID: 29931469
-
Chromosome 3 status in uveal melanoma: a comparison of fluorescence in situ hybridization and single-nucleotide polymorphism array.Invest Ophthalmol Vis Sci. 2012 Jun 5;53(7):3331-9. doi: 10.1167/iovs.11-9027. Invest Ophthalmol Vis Sci. 2012. PMID: 22511634 Free PMC article.
References
-
- Singh AD, Topham A. Incidence of uveal melanoma in the United States: 1973–1997. Ophthalmol 2003;110:956–61. - PubMed
-
- Diener-West M , Hawkins BS, Markowitz JA, et al. A review of mortality from choroidal melanoma. II. A meta-analysis of 5-year mortality rates following enucleation, 1966 through 1988. Arch Ophthalmol 1992;110:245–50. - PubMed
-
- Bergman L , Seregard S, Nilsson B, et al. Uveal melanoma survival in Sweden from 1960 to 1998. A review of mortality from choroidal melanoma. II. A meta-analysis of 5-year mortality rates following enucleation, 1966 through 1988. Invest Ophthalmol Vis Sci 2003;44:3282–7. - PubMed
-
- Kath R , Hayungs J, Bornfeld N, et al. Prognosis and treatment of disseminated uveal melanoma. Cancer 1993;72:2219–23. - PubMed
-
- Newton FH. Malignant melanoma of choroid. Report of a case with clinical history of 36 years and follow up of 32 years. Arch Ophthalmol 1965;73:198–9. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical